Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SONNO - Sleep Spindles Organization as an Early Neural Marker of Neuromotor Outcome: a New, Fast, Safe, Cost-effective and Infant-friendly EEG Tool to Monitor Early Sensory-motor Function in Infants at Risk of Neuromotor Disorders.

NCT06256887 is registered in ClinicalTrials.gov with IRCCS Fondazione Stella Maris as lead sponsor.

NCT NCT06256887
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06256887 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SONNO - Sleep Spindles Organization as an Early Neural Marker of Neuromotor Outcome: a New, Fast, Safe, Cost-effective and Infant-friendly EEG Tool to Monitor Early Sensory-motor Function in Infants at Risk of Neuromotor Disorders.
Lead sponsor
IRCCS Fondazione Stella Maris
Phase
Observational
Overall status
Unknown status
Start date
November 30, 2023
Completion date
April 30, 2026
Enrollment
80 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral palsy, eeg sleep spindles, motor outcome, sma1